Universitat de Barcelona
2020-06-09T21:16:11Z
2020-06-09T21:16:11Z
2019-04
2020-06-09T21:16:11Z
Phenylketonuria is a well-known rare disease included in the neonatal screening of many countries. Therefore, there are few published data on the admissions and costs of phenylketonuria in Spain. (...) The objective of this study was to assess the number of admissions and the economic burden of phenylketonuria in Spain. (...)
Article
Versió acceptada
Anglès
Cost de l'assistència sanitària; Fenilcetonúria; Administració sanitària; Ingressos i altes en els hospitals; Cost of medical care; Phenylketonuria; Health services administration; Hospital admission and discharge
Springer Nature
Versió postprint del document publicat a: https://doi.org/10.1007/s40261-019-00760-1
Clinical Drug Investigation, 2019, vol. 39, num. 4, p. 379-384
https://doi.org/10.1007/s40261-019-00760-1
(c) Springer Nature, 2019
Economia [1047]
